United States Antimony Corporation stocks have been trading up by 13.64 percent amid upbeat antimony demand and pricing outlook news
Click Here for a Millionaire's POV on Trading UAMY
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- Q1 2026 brought a wider EPS loss and a big revenue miss, but management flagged multiple long-term growth drivers across antimony and tungsten.
- Full-year 2026 revenue guidance around $125M was reaffirmed, signaling confidence despite near-term pressure.
- A key analyst, H.C. Wainwright, nudged its UAMY price target up to $11.75 and kept a Buy rating following earnings.
- The Fostung tungsten acquisition and a sizable Defense Logistics Agency contract expand UAMY’s critical-minerals footprint.
- Operational restart at Stibnite Hill and a new Defense Production Act award reinforce UAMY’s role in the U.S. strategic supply chain.
Live Update At 12:32:38 EDT: On Wednesday, May 20, 2026 United States Antimony Corporation stock [NYSE: UAMY] is trending up by 13.64%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
UAMY has been trading like a rollercoaster. On the daily chart, United States Antimony ran from about $9.60 on 2026/04/27 to a spike above $12.50, then bled down toward the mid‑$8s by 2026/05/20. That’s heavy volatility and the kind of range active traders look for.
Intraday, UAMY’s tape on the latest session shows a steady grind higher. Pre‑market action around $7.50–$7.80 turned into a regular‑hours push from the high‑$7s to a close near $8.46. The 5‑minute candles show higher lows and controlled dips being bought, a classic trending day where dip‑buyers stayed in charge.
Fundamentally, UAMY is still in turnaround mode. Q1 2026 revenue came in at $6.78M while the company posted a net loss of about $11.3M and EPS of -$0.08, missing the -$0.02 consensus and highlighting current unprofitability. Margins are negative across EBIT and net income, and free cash flow was roughly -$24.6M for the quarter, driven by heavy capital spending.
More Breaking News
- UAMY Stock Draws Traders As Guidance Holds And Strategic Deals Mount
- LPG Stock Jumps As Dividend And Analyst Upgrade Fuel Rally
- SOFI Stock Slumps As Legal, Analyst Pressure Mounts
- AMC Stock Draws Bullish Targets As Recovery Story Builds
But the balance sheet gives UAMY some breathing room. With total debt effectively minimal and a current ratio around 5.4, liquidity isn’t the immediate problem. For traders, that means UAMY is a speculative growth and contract story, not a near-term distress play, and price action will likely hinge on execution against guidance.
Why Traders Are Watching UAMY Right Now
United States Antimony is a textbook case of “ugly quarter, big story.” On 2026/05/14, UAMY reported that -$0.08 EPS loss and only $6.78M in revenue versus $14.83M expected. On headline numbers alone, that’s brutal and explains why the stock has pulled back from the $12 zone. But management spent that update laying out a much bigger chessboard.
First, UAMY reaffirmed 2026 revenue guidance at about $125M, in line with the $124.8M FactSet consensus. When a company misses this hard in the short term yet refuses to cut guidance, it tells traders one thing: they see the current drag as timing, not a broken story. The Street seemed to agree. Within days, H.C. Wainwright raised its price target on United States Antimony from $11.50 to $11.75 and reiterated a Buy rating, signaling that at least one major firm is focused on the pipeline, not the last quarter.
That pipeline is where UAMY gets interesting. The company has a sole‑source antimony contract with the U.S. Defense Logistics Agency worth up to $245M and just issued its first delivery notice under that deal. It is also progressing the Thompson Falls smelter expansion and has acquired the Radersburg flotation mill, both aimed at boosting processing capacity. On top of that, UAMY is restarting mining at Stibnite Hill and has secured a Defense Production Act award, lining up government support with operational ramp‑ups.
The new Fostung tungsten project in Ontario adds another layer. A technical report suggests potential life‑of‑mine revenue of about $4.6B from that tungsten asset. If UAMY becomes the first North American tungsten producer in over a decade, the ticker shifts from being a niche antimony name to a broader critical‑minerals platform. For momentum traders, that combination of government‑backed contracts, asset growth, and sector buzz is exactly what fuels multi‑day runs when the chart lines up.
Conclusion
United States Antimony is far from a clean earnings story. UAMY’s margins are negative, Q1 2026 free cash flow is deep in the red, and the company is spending heavily to build capacity. There’s also a temporary CFO shuffle, with Richard Isaak on personal leave and former consultant Shawn Winkler stepping in as interim CFO. Normally, that kind of C‑suite change would spook the market. Here, shares actually jumped roughly 8–9% on the news, a sign traders accepted the “personal reasons” explanation and may even welcome added financial oversight as UAMY scales.
So what does this all mean for UAMY on the screen? You have a low‑debt balance sheet, reaffirmed $125M revenue guidance, a $245M DLA contract, a Defense Production Act award, the Stibnite restart, the Radersburg mill acquisition, and the Fostung tungsten optionality. At the same time, you have a stock that just sold off from the low‑$12s into the high‑$7s and is now trying to base around the mid‑$8s.
For active traders, that mix of weak current earnings and strong forward catalysts often creates powerful trading setups. The key is to treat UAMY as a trading vehicle, not a marriage. As Tim Sykes likes to hammer home, “The trend is your friend, but only if you cut losses quickly when that trend breaks.” As Tim Bohen, lead trainer with StocksToTrade says, “There’s a pattern in everything; you just have to stick around long enough to see it.” Apply that mindset to UAMY’s wild swings, study the news around its contracts and projects, and let the price action confirm whether the market is ready to believe the long‑term story. This analysis is for educational and research purposes only and is not investment advice.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.